相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Colorectal cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5-Fluorouracil Therapy
Jan H. Beumer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
Development, validation and application of a novel liquid chromatography tandem mass spectrometry assay measuring uracil, 5,6-dihydrouracil, 5-fluorouracil, 5,6-dihydro-5-fluorouracil, α-fluoro-β-ureidopropionic acid and α-fluoro-β-alanine in human plasma
Ottiniel Chavani et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2017)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Therapeutic drug monitoring of 5-fluorouracil
James J. Lee et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Pharmacokinetic and Pharmacodynamic Analyses of 5-Fluorouracil in East-Asian Patients with Nasopharyngeal Carcinoma
Yuxiang Ma et al.
CLINICAL PHARMACOKINETICS (2016)
Determining the optimal 5-FU therapeutic dosage in the treatment of colorectal cancer patients
Ling Fang et al.
ONCOTARGET (2016)
A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer
Bengt Gustavsson et al.
CLINICAL COLORECTAL CANCER (2015)
Population Pharmacokinetic Analysis of 5-FU and 5-FDHU in Colorectal Cancer Patients: Search for Biomarkers Associated with Gastro-Intestinal Toxicity
Christian Woloch et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Modeling the 5-Fluorouracil Area Under the Curve Versus Dose Relationship to Develop a Pharmacokinetic Dosing Algorithm for Colorectal Cancer Patients Receiving FOLFOX6
Rajesh R. Kaldate et al.
ONCOLOGIST (2012)
Body Surface Area-based Dosing of 5-Fluoruracil Results in Extensive Interindividual Variability in 5-Fluorouracil Exposure in Colorectal Cancer Patients on FOLFOX Regimens
Jennifer Saam et al.
CLINICAL COLORECTAL CANCER (2011)
Pharmacokinetically Guided Dose Adjustment of 5-Fluorouracil: A Rational Approach to Improving Therapeutic Outcomes
M. Wasif Saif et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
How may anticancer chemotherapy with fluorouracil be individualised?
Su-arpa Ploylearmsaeng et al.
CLINICAL PHARMACOKINETICS (2006)
Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients
F Casale et al.
PHARMACOLOGICAL RESEARCH (2004)
Relationship between plasma concentrations of 5-fluorouracil and 5-fluoro-5,6-dihydrouracil and toxicity of 5-fluorouracil infusions in cancer patients
A Di Paolo et al.
THERAPEUTIC DRUG MONITORING (2002)
α-fluoro-β-alanine:: Effects on the antitumor activity and toxicity of 5-fluorouracil
SS Cao et al.
BIOCHEMICAL PHARMACOLOGY (2000)
分享论文
